Abstract | BACKGROUND: METHODS: RESULTS: mRNAs encoding toll-like receptors 2 and 4 and myeloid differentiation protein-2 were significantly up-regulated in group AV as compared to control groups at 2 - 24 hours of sepsis; peak expression occurred at 12 hours. These mRNAs were also up-regulated in group AVA but to lesser degrees than in group AV at comparable time post- infection. mRNAs encoding TNF-alpha, IL-1beta and IL-6 were significantly elevated in group AV as a function of infection. In group AVA as compared to AV, expression of TNF-alpha and IL-1beta mRNAs was lower at 12 - 24 hours post- infection and expression of IL-6 mRNA was lower at 24 hours post- infection. Compared with control groups, IL-10 mRNA expression in group AV was markedly higher at 12 - 24 hours of sepsis. Expression of IL-10 mRNA was lower in group AVA as compared to AV at 24 hours of sepsis. CONCLUSIONS:
|
Authors | Zhong-qiu Lu, Meng-fang Li, Qiao-meng Qiu, Huang Liang, Tie-li Zhou, Guang-liang Hong, Bin Wu |
Journal | Chinese medical journal
(Chin Med J (Engl))
Vol. 122
Issue 16
Pg. 1910-6
(Aug 20 2009)
ISSN: 2542-5641 [Electronic] China |
PMID | 19781370
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adaptor Proteins, Signal Transducing
- Anti-Infective Agents
- Cytokines
- Interleukin-1beta
- Interleukin-6
- Toll-Like Receptor 2
- Toll-Like Receptor 4
- Toll-Like Receptors
- Tumor Necrosis Factor-alpha
- Interleukin-10
|
Topics |
- Adaptor Proteins, Signal Transducing
(genetics)
- Animals
- Anti-Infective Agents
(therapeutic use)
- Cytokines
(genetics)
- Interleukin-10
(genetics)
- Interleukin-1beta
(genetics)
- Interleukin-6
(genetics)
- Liver
(drug effects, metabolism)
- Liver Diseases, Alcoholic
(drug therapy, metabolism)
- Male
- Rats
- Rats, Sprague-Dawley
- Reverse Transcriptase Polymerase Chain Reaction
- Sepsis
(drug therapy, genetics, microbiology)
- Toll-Like Receptor 2
(genetics)
- Toll-Like Receptor 4
(genetics)
- Toll-Like Receptors
(genetics)
- Tumor Necrosis Factor-alpha
(genetics)
- Vibrio Infections
(drug therapy)
- Vibrio vulnificus
(physiology)
|